{"content":"<li class=\"n-box-item date-title\" data-end=\"1420001999\" data-start=\"1419915600\" data-txt=\"Saturday, December 21, 2019\">Tuesday, December 30, 2014</li><li class=\"n-box-item sa-box-item\" data-id=\"2200655\" data-ts=\"1419979001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200655-after-hour-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hour Gainers / Losers</a></h4><ul><li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/RUSS' title='Direxion Daily Russia Bear 3x Shares ETF'>RUSS</a> <font color='green'>+3.3%</font>. STV <font color='green'>+3.3%</font>. VIP <font color='green'>+2.9%</font>. <a href='https://seekingalpha.com/symbol/CVEO' title='Civeo Corporation'>CVEO</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='green'>+2.4%</font>.</li><li><b>Top losers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/BMO' title='Bank of Montreal'>BMO</a> <font color='red'>-3.8%</font>. <a href='https://seekingalpha.com/symbol/AMS' title='American Shared Hospital Services'>AMS</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/RUSL' title='Direxion Daily Russia Bull 3x Shares ETF'>RUSL</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='red'>-2.5%</font>. <a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='red'>-2.0%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"2200655\" data-linked=\"After Hour Gainers / Losers\" data-tweet=\"$RUSS $STVVY $VEON - After Hour Gainers / Losers https://seekingalpha.com/news/2200655-after-hour-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2200655-after-hour-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200645\" data-ts=\"1419976867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANRZQ\" target=\"_blank\">ANRZQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200645-alpha-natural-closes-86m-sale-of-pennsylvania-mines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alpha Natural closes $86M sale of Pennsylvania mines</a></h4><ul>\n<li>Alpha Natural (ANR) has closed the sale of its Amfire Mining Co. subsidiary to Rosebud Mining for $86M - $75M in cash + the assumption of liabilities. Amfire owns ten mines and four preparation plants/loadouts located in seven Pennsylvania counties.</li>\n<li>Alpha still owns two mines in Southwestern Pennsyvania. The company had $1.2B in cash/short-term investments at the end of September, and $3.9B in debt.</li>\n<li>Shares <font color=\"green\">rose 5.9%</font> in regular trading.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200645\" data-linked=\"Alpha Natural closes $86M sale of Pennsylvania mines\" data-tweet=\"$ANRZQ - Alpha Natural closes $86M sale of Pennsylvania mines https://seekingalpha.com/news/2200645-alpha-natural-closes-86m-sale-of-pennsylvania-mines?source=tweet\" data-url=\"https://seekingalpha.com/news/2200645-alpha-natural-closes-86m-sale-of-pennsylvania-mines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200595\" data-ts=\"1419974920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNH\" target=\"_blank\">HNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200595-steel-partners-goes-hostile-on-jps-industries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Partners goes hostile on JPS Industries</a></h4><ul>\n<li>Handy &amp; Harman (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HNH\" title=\"Handy &amp; Harman Ltd.\">HNH</a>) parent Steel Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/SPLP\" title=\"Steel Partners Holdings L.P.\">SPLP</a>) currently owns 39% of JPS Industries (BATS:<a href=\"https://seekingalpha.com/symbol/JPST\" title=\"JPMorgan Ultra-Short Income ETF\">JPST</a>) shares, and HNH is bidding for the rest for $10 per share in cash.</li>\n<li>Steel Partners has been working with JPS management for some time to try and buy the company or sell it to a third party.</li>\n<li>The stock closed last night at $6.92, and closed today's regular session at $7.46.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200595\" data-linked=\"Steel Partners goes hostile on JPS Industries\" data-tweet=\"$HNH $HNH $SPLP - Steel Partners goes hostile on JPS Industries https://seekingalpha.com/news/2200595-steel-partners-goes-hostile-on-jps-industries?source=tweet\" data-url=\"https://seekingalpha.com/news/2200595-steel-partners-goes-hostile-on-jps-industries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200555\" data-ts=\"1419974306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IAG\" target=\"_blank\">IAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200555-gold-and-silver-stocks-up-strongly-as-dollar-slides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold and silver stocks up strongly as dollar slides</a></h4><ul>     <li>With the dollar falling against the yen and pound and a minor flight to safety afoot - Treasurys are higher, stocks have closed moderately lower - COMEX gold is <font color=\"green\">up 1.4%</font> today to $1,197/oz., and COMEX silver is <font color=\"green\">up 2.6%</font> to $16.20/oz. The gains have provided a lift to the volatile/beaten-down shares of gold and silver miners.</li>     <li>Notable gold gainers: <a href=\"https://seekingalpha.com/symbol/IAG\" title=\"IAMGOLD Corporation\">IAG</a> <font color=\"green\">+11.7%</font>. ABX <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/AUY\" title=\"Yamana Gold Inc.\">AUY</a> <font color=\"green\">+5.2%</font>. <a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/GG\" title=\"Goldcorp Inc.\">GG</a> <font color=\"green\">+4.6%</font>. <a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"green\">+4.2%</font>. <a href=\"https://seekingalpha.com/symbol/SBGL\" title=\"Sibanye-Stillwater\">SBGL</a> <font color=\"green\">+4.9%</font>. <a href=\"https://seekingalpha.com/symbol/KGC\" title=\"Kinross Gold Corporation\">KGC</a> <font color=\"green\">+4.1%</font>. <a href=\"https://seekingalpha.com/symbol/AGI\" title=\"Alamos Gold Inc\">AGI</a> <font color=\"green\">+5%</font>. <a href=\"https://seekingalpha.com/symbol/AEM\" title=\"Agnico Eagle Mines Limited\">AEM</a> <font color=\"green\">+5.1%</font>.</li>     <li>Notable silver gainers: <a href=\"https://seekingalpha.com/symbol/AG\" title=\"First Majestic Silver Corp.\">AG</a> <font color=\"green\">+7.6%</font>. <a href=\"https://seekingalpha.com/symbol/SVM\" title=\"Silvercorp Metals Inc.\">SVM</a> <font color=\"green\">+7.1%</font>. <a href=\"https://seekingalpha.com/symbol/SSRI\" title=\"SSR Mining Inc\">SSRI</a> <font color=\"green\">+6.2%</font>. <a href=\"https://seekingalpha.com/symbol/SVM\" title=\"Silvercorp Metals Inc.\">SVM</a> <font color=\"green\">+6.4%</font>. <a href=\"https://seekingalpha.com/symbol/PAAS\" title=\"Pan American Silver Corp.\">PAAS</a> <font color=\"green\">+3.9%</font>. <a href=\"https://seekingalpha.com/symbol/SVLC\" title=\"SilverCrest Mines, Inc.\">SVLC</a> <font color=\"green\">+5.2%</font>. <a href=\"https://seekingalpha.com/symbol/EXK\" title=\"Endeavour Silver Corp.\">EXK</a> <font color=\"green\">+6.9%</font>.</li>     <li>ETFs with 3%+ gains: <a href=\"https://seekingalpha.com/symbol/NUGT\" title=\"Direxion Daily Gold Miners Index Bull 3x Shares ETF\">NUGT</a> <font color=\"green\">+10.1%</font>. <a href=\"https://seekingalpha.com/symbol/GDXJ\" title=\"VanEck Vectors Junior Gold Miners ETF\">GDXJ</a> <font color=\"green\">+5.1%</font>. <a href=\"https://seekingalpha.com/symbol/USLV\" title=\"VelocityShares 3x Long Silver ETN\">USLV</a> <font color=\"green\">+9.7%</font>. <a href=\"https://seekingalpha.com/symbol/UBG\" title=\"UBS ETRACS CMCI Gold Total Return ETN\">UBG</a> <font color=\"green\">+5.4%</font>. <a href=\"https://seekingalpha.com/symbol/USV\" title=\"UBS ETRACS CMCI Silver Total Return ETN\">USV</a> <font color=\"green\">+3.8%</font>. <a href=\"https://seekingalpha.com/symbol/SIVR\" title=\"Aberd Std Silvr Shs\">SIVR</a> <font color=\"green\">+3.4%</font>. <a href=\"https://seekingalpha.com/symbol/AGQ\" title=\"ProShares Ultra Silver ETF\">AGQ</a> <font color=\"green\">+6.3%</font>. <a href=\"https://seekingalpha.com/symbol/BAR-OLD\" title=\"Direxion Daily Gold Bull 3X Shares ETF\">BAR-OLD</a> <font color=\"green\">+3.2%</font>. <a href=\"https://seekingalpha.com/symbol/DBS\" title=\"Invesco DB Silver ETF\">DBS</a> <font color=\"green\">+3.2%</font>.</li>     <li>The group <a href=\"https://seekingalpha.com/news/2197515-gold-and-silver-stocks-rally-on-china-hopes\" target=\"_blank\">rallied on Friday</a> after the PBOC relaxed lending rules for banks, but sold off on Monday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2200555\" data-linked=\"Gold and silver stocks up strongly as dollar slides\" data-tweet=\"$IAG $IAG $GOLD - Gold and silver stocks up strongly as dollar slides https://seekingalpha.com/news/2200555-gold-and-silver-stocks-up-strongly-as-dollar-slides?source=tweet\" data-url=\"https://seekingalpha.com/news/2200555-gold-and-silver-stocks-up-strongly-as-dollar-slides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200525\" data-ts=\"1419973768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGMD\" target=\"_blank\">BGMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200525-bg-medicine-up-big-on-approval-of-automated-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BG Medicine up big on approval of automated test</a></h4><ul><li>Thinly-traded nano cap BG Medicine (<a href=\"https://seekingalpha.com/symbol/BGMD\" title=\"BG Medicine, Inc.\">OTC:BGMD</a>) jumps <font color=\"green\">63%</font> on a massive 17x surge in volume in response the FDA clearance of the automated version of its <a href=\"http://www.bg-medicine.com/bgm-galectin-3-test/\" target=\"_blank\">galectin-3</a> test. The test will marketed by Abbott Laboratories' (NYSE:<a href=\"https://seekingalpha.com/symbol/ABT\" title=\"Abbott Laboratories\">ABT</a>) Diagnostics Division as part of the test menu of its <a href=\"https://www.abbottdiagnostics.com/en-us/products/ARCHITECT-c4000.html\" target=\"_blank\">Architect </a>fully-automated immunoassay analyzer.</li></ul><div class=\"tiny-share-widget\" data-id=\"2200525\" data-linked=\"BG Medicine up big on approval of automated test\" data-tweet=\"$BGMD $BGMD $ABT - BG Medicine up big on approval of automated test https://seekingalpha.com/news/2200525-bg-medicine-up-big-on-approval-of-automated-test?source=tweet\" data-url=\"https://seekingalpha.com/news/2200525-bg-medicine-up-big-on-approval-of-automated-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200465\" data-ts=\"1419972550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZGNX\" target=\"_blank\">ZGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200465-money-flows-into-zogenix-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Money flows into Zogenix today</a></h4><ul>\n<li>Micro cap Zogenix (<a href=\"https://seekingalpha.com/symbol/ZGNX\" title=\"Zogenix, Inc.\">ZGNX</a> <font color=\"green\">+8.1%</font>) gives long-suffering longs a bit of hope today on a 2.5x surge in volume. Shares plummeted 79% from the February 13 high of $5.19 to the December 16 low of $1.08.</li>\n<li>Yesterday, Brean Capital initiated <a href=\"http://www.thestreet.com/story/12996981/1/zogenix-zgnx-stock-gets-a-boost-today-from-this-coverage-initiation.html?puc=stocktwits&amp;cm_ven=STOCKTWITS&amp;utm_source=dlvr.it&amp;utm_medium=organic&amp;utm_campaign=stocktwits\" target=\"_blank\">coverage </a>with a Buy rating and $2.50 price target.</li>\n<li>The PDUFA date for its sNDA for an abuse deterrent formulation of Zohydro ER (hydrocodone bitartrate) is January 30.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2009635-zogenix-submits-snda-for-abuse-deterrent-zohydro\" target=\"_blank\">Zogenix submits sNDA for abuse deterrent Zohydro</a> (Oct. 1)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200465\" data-linked=\"Money flows into Zogenix today\" data-tweet=\"$ZGNX - Money flows into Zogenix today https://seekingalpha.com/news/2200465-money-flows-into-zogenix-today?source=tweet\" data-url=\"https://seekingalpha.com/news/2200465-money-flows-into-zogenix-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200435\" data-ts=\"1419971391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200435-molycorp-up-21-percent-over-last-three-trading-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molycorp up 21% over last three trading days</a></h4><ul>\n<li>Molycorp (MCP <font color=\"green\">+2.8%</font>) is closing out a very rough 2014 on a strong note. Both Tuesday and Wednesday's gains have come on above-average volume.</li>\n<li>Liquidity/solvency concerns have weighed heavily on the rare-earth miner's shares - it ended Q3 with $1.6B in debt and capital lease obligations to go with $314M in cash, and is <a href=\"http://finance.yahoo.com/q/ae?s=mcp&amp;ql=1\" target=\"_blank\">expected</a> to lose $0.34/share in Q4 and $0.62/share in 2015. A $207M debt maturity is due in June 2016.</li>\n<li>Three weeks ago, <a href=\"http://www.streetinsider.com/Credit+Ratings/UPDATE%3A+S%26P+Raises+Molycorp+%28MCP%29+to+CCC%2B%3B+Sees+Average+Recovery+of+Principal%2C+Interest+in+Default/10087289.html\" target=\"_blank\">S&amp;P upgraded</a> its rating for Molycorp's senior secured debt to CCC+ (still in junk territory), but also lowered its debt recovery expectations in the event of a default. A $38M <a href=\"https://seekingalpha.com/article/2706605-molycorp-hits-52-week-low-on-debt-for-equity-swap\" target=\"_blank\">debt-for-equity swap</a> was carried out in November.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200435\" data-linked=\"Molycorp up 21% over last three trading days\" data-tweet=\"$MCPIQ - Molycorp up 21% over last three trading days https://seekingalpha.com/news/2200435-molycorp-up-21-percent-over-last-three-trading-days?source=tweet\" data-url=\"https://seekingalpha.com/news/2200435-molycorp-up-21-percent-over-last-three-trading-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200425\" data-ts=\"1419970431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200425-twitter-slides-after-barrons-looks-at-insider-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter slides after Barron&#39;s looks at insider sales</a></h4><ul>\n<li>Via Rule 10b5-1 trading plans, seven Twitter (<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a> <font color=\"red\">-2%</font>) insiders unloaded 1.18M shares from Dec. 1-23 at an average price of $37.99, <a href=\"http://online.barrons.com/articles/twitter-co-founder-williams-sells-28m-in-stock-1419891897\" target=\"_blank\">observes <em>Barron's</em></a>.</li>\n<li>Co-founder/ex-CEO Evan Williams sold 744K shares, and (as <a href=\"https://seekingalpha.com/news/2193305-twitter-spikes-thanks-to-costolo-resignation-rumor\" target=\"_blank\">previously noted</a>) embattled CEO Dick Costolo sold his remaining indirect stake of 283K shares. Williams still owns 719K shares; Costolo directly owns 546K.</li>\n<li>The other sellers: General counsel Vijay Gadde, product VP Kevin Weil, engineering VP Alexander Roetter, ad chief Adam Bain, and finance VP Luca Baratta.</li>\n<li>Twitter is about a dollar above a 6-month low of $34.62. Shares <font color=\"red\">-44%</font> YTD, and trading for 9.8x 2015E sales.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200425\" data-linked=\"Twitter slides after Barron&#39;s looks at insider sales\" data-tweet=\"$TWTR - Twitter slides after Barron&#39;s looks at insider sales https://seekingalpha.com/news/2200425-twitter-slides-after-barrons-looks-at-insider-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/2200425-twitter-slides-after-barrons-looks-at-insider-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200395\" data-ts=\"1419968673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEON\" target=\"_blank\">NEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200395-neonode-up-18_6-percent-following-bullish-cowen-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neonode up 18.6% following bullish Cowen note</a></h4><ul>\n<li>Neonode (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NEON\" title=\"Neonode, Inc.\">NEON</a>) and Synaptics are likely to benefit from positive CES news flow, says Cowen, reiterating Outperform ratings for both. While Synaptics ($2.6B market cap) is nonetheless trading lower, Neonode ($104M market cap) has blasted off thanks to the note.</li>\n<li>\n<a href=\"http://www.thestreet.com/story/12997039/1/neonode-neon-stock-higher-today-ahead-of-januarys-touch-technology-showcase.html\" target=\"_blank\">Cowen</a> sees PC touch sensor solutions to be unveiled at CES acting as a positive catalyst. Neonode stated in its Q3 report it's \"in business discussions with a majority of the major OEM's and ODM's in the PC segment.\" However, on the CC (<a href=\"https://seekingalpha.com/article/2666685-neonodes-neon-ceo-thomas-eriksson-on-q3-2014-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), the company disclosed its \"first major contract in the PC space has taken a bit longer to finish than we originally estimated.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200395\" data-linked=\"Neonode up 18.6% following bullish Cowen note\" data-tweet=\"$NEON - Neonode up 18.6% following bullish Cowen note https://seekingalpha.com/news/2200395-neonode-up-18_6-percent-following-bullish-cowen-note?source=tweet\" data-url=\"https://seekingalpha.com/news/2200395-neonode-up-18_6-percent-following-bullish-cowen-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200345\" data-ts=\"1419966502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LIVE\" target=\"_blank\">LIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200345-livedeal-gives-back-a-big-chunk-of-yesterdays-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LiveDeal gives back a big chunk of yesterday&#39;s gains</a></h4><ul><li>Up 19% yesterday after posting <a href=\"https://seekingalpha.com/news/2198185-livedeal-misses-by-0_01-beats-on-revenue\" target=\"_blank\">FY14 results</a> that included <a href=\"https://seekingalpha.com/news/2198405-livedeal-plus-21_3-percent-following-fy14-report\" target=\"_blank\">marketplace platform revenue</a> of $5.27M, LiveDeal (<a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-12.5%</font>) has sharply reversed course today.</li><li>SA author IAEResearch has offered <a href=\"https://seekingalpha.com/article/2787275-update-livedeal-remains-a-speculative-play-despite-a-reduction-in-net-losses\" target=\"_blank\">a cautious take</a> on the FY14 numbers. \"The results confirm our view that the company will be able to grow its revenues through acquisitions ... the strategy has been paying off for the company as it has been able to reduce its losses and increase its cash balances. However, we still remain cautious as the barriers to entry are almost non-existent and the customer loyalty is also questionable.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"2200345\" data-linked=\"LiveDeal gives back a big chunk of yesterday&#39;s gains\" data-tweet=\"$LIVE - LiveDeal gives back a big chunk of yesterday&#39;s gains https://seekingalpha.com/news/2200345-livedeal-gives-back-a-big-chunk-of-yesterdays-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/2200345-livedeal-gives-back-a-big-chunk-of-yesterdays-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200255\" data-ts=\"1419961789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWN\" target=\"_blank\">SWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200255-southwestern-down-6-percent-after-setting-2015-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwestern down 6% after setting 2015 guidance</a></h4><ul>\n<li>Southwestern Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/SWN\" title=\"Southwestern Energy Co.\">SWN</a>) has guided for 2015 production of 970-980 Bcfe - natural gas production of 902-912 Bcf, oil production of 2,025-2,065 MBbls, and NGL production of 9,325-9,365 MBbls. Production is expected to reach 1,310-1,340 Bcfe in 2017. A year ago, the company guided for 2014 production of 740-753 Bcfe.</li>\n<li>The 2014 capex budget has been set at $2.6B, up from 2014's $2.45B. $755M, $790M, and $625M will respectively be spent on Fayetteville Shale, Northeast Appalachia, and Southwest Appalachia.</li>\n<li>Net operating well count is expected to rise to 435-460 from 2014's 412. Gross well count is expected to rise to 540-560 from 525, and reach 665-685 in 2017.</li>\n<li>At a NYMEX gas price of $3.75/mmBtu, and an oil price of $70/barrel, Southwestern expects to produce $560M-$580M in net income and $2.235B-$2.255B in net cash flow. Current prices are, of course, <a href=\"http://www.bloomberg.com/energy/\" target=\"_blank\">much lower</a>.</li>\n<li>Shares have fallen to new 52-week lows in spite of an upgrade to Overweight from CapitalOne. <a href=\"https://seekingalpha.com/news/2193325-barrons-sees-60-percent-upside-for-southwestern-energy-as-natural-gas-play\" target=\"_blank\"><em>Barron's</em></a> made a bull case for Southwestern a week ago.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200255\" data-linked=\"Southwestern down 6% after setting 2015 guidance\" data-tweet=\"$SWN - Southwestern down 6% after setting 2015 guidance https://seekingalpha.com/news/2200255-southwestern-down-6-percent-after-setting-2015-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/2200255-southwestern-down-6-percent-after-setting-2015-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200245\" data-ts=\"1419961734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200245-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><b>Top 10 Gainers:</b> <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+88%</font>. <a href='https://seekingalpha.com/symbol/NPD' title='China Nepstar Chain Drugstore Ltd.'>NPD</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/VTNR' title='Vertex Energy, Inc.'>VTNR</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ARWR' title='Arrowhead Pharmaceuticals'>ARWR</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CJJD' title='China Jo - Jo Drugstores, Inc.'>CJJD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/AMS' title='American Shared Hospital Services'>AMS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color='green'>+14%</font>.</li><li><b>Top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/CVEO' title='Civeo Corporation'>CVEO</a> <font color='red'>-51%</font>. <a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/JOB' title='GEE Group, Inc.'>JOB</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/IMDZ' title='Immune Design'>IMDZ</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/JST' title='Jinpan International Limited'>JST</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ZAZA' title='ZaZa Energy Corp'>OTC:ZAZA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ESSX' title='Essex Rental Corp.'>OTC:ESSX</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DRYS' title='DryShips Inc.'>DRYS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ENSV' title='Enservco Corp.'>ENSV</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"2200245\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$NDRM $NPD $SEED - Midday Gainers / Losers https://seekingalpha.com/news/2200245-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2200245-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200225\" data-ts=\"1419960406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARWR\" target=\"_blank\">ARWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200225-arrowhead-up-on-rumor-of-gilead-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arrowhead up on rumor of Gilead interest</a></h4><ul>\n<li>Small cap Arrowhead Research (<a href=\"https://seekingalpha.com/symbol/ARWR\" title=\"Arrowhead Pharmaceuticals\">ARWR</a> <font color=\"green\">+17.5%</font>) is up on 50% higher volume on rumors that Gilead Sciences (<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a> <font color=\"red\">-0.9%</font>) may be eyeing the company for its RNA interference-based drugs.</li>\n<li>Arrowhead has yet to recover from the plunge in October after it reported Phase 2a results for its hepatitis B candidate, ARC-520, that fell short of investors' expectations.</li>\n<li>Gilead has <a href=\"http://www.gilead.com/research/pipeline\" target=\"_blank\">three drugs in development</a> for the treatment of chronic HBV infection: <a href=\"http://en.wikipedia.org/wiki/Tenofovir_alafenamide_fumarate\" target=\"_blank\">tenofovir alafanamide</a>, a nucleotide reverse transcriptase inhibitor, GS-4774, a <a href=\"http://www.globeimmune.com/platform/technology/\" target=\"_blank\">Tarmogen </a>T cell immunity stimulator and GS-9620, a <a href=\"http://en.wikipedia.org/wiki/Toll-like_receptor\" target=\"_blank\">TLR-7</a> agonist in addition to the commercially available <a href=\"http://www.viread.com/\" target=\"_blank\">Viread </a>(tenofovir disoproxil fumarate) and <a href=\"http://www.gilead.com/~/media/Files/pdfs/medicines/liver-disease/hepsera/hepsera_pi.pdf\" target=\"_blank\">Hepsera </a>(adefovir dipivoxil).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2022605-arrowhead-explains-the-arcminus-520-data\" target=\"_blank\">Arrowhead explains the ARC-520 data</a> (Oct. 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200225\" data-linked=\"Arrowhead up on rumor of Gilead interest\" data-tweet=\"$ARWR $ARWR $GILD - Arrowhead up on rumor of Gilead interest https://seekingalpha.com/news/2200225-arrowhead-up-on-rumor-of-gilead-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/2200225-arrowhead-up-on-rumor-of-gilead-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200215\" data-ts=\"1419959989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200215-expedia-slumps-after-fbr-warns-u-s-bookings-could-be-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Expedia slumps after FBR warns U.S. bookings could be light</a></h4><ul><li>Believing growth has slowed in December, FBR's Jake Fuller thinks Expedia (<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a> <font color='red'>-2.8%</font>) <a href=\"http://www.streetinsider.com/Analyst+Comments/Expedia+%28EXPE%29+Trends+Healthy+But+Q4+U.S.+Booking+Consensus+May+Be+High+-+FBR+Capital/10125811.html\" target=\"_blank\">could miss</a> a Q4 U.S. bookings consensus for high-20s growth.</li><li>Fuller, who maintains an Outperform rating and $100 target, thinks air ticket growth has slowed in Q4, and expects tougher comps (due to Expedia's Travelocity deal going into effect a year ago) to also weigh on December growth. He still thinks the company can hit a 23% global bookings growth consensus, since it doesn't yet account for the <a href=\"https://seekingalpha.com/news/1830645-expedia-agrees-to-buy-wotif-for-660m\" target=\"_blank\">Wotif acquisition</a>.</li><li>Expedia's Q3 U.S. bookings rose 35% Y/Y (thanks in part to Travelocity), and made up 58% of total bookings.</li></ul><div class=\"tiny-share-widget\" data-id=\"2200215\" data-linked=\"Expedia slumps after FBR warns U.S. bookings could be light\" data-tweet=\"$EXPE - Expedia slumps after FBR warns U.S. bookings could be light https://seekingalpha.com/news/2200215-expedia-slumps-after-fbr-warns-u-s-bookings-could-be-light?source=tweet\" data-url=\"https://seekingalpha.com/news/2200215-expedia-slumps-after-fbr-warns-u-s-bookings-could-be-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200145\" data-ts=\"1419956909\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200145-yelp-gains-following-bullish-mkm-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp gains following bullish MKM note</a></h4><ul>\n<li>Whereas Yelp's (<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a> <font color=\"green\">+2.6%</font>) current valuation implies meaningful growth deceleration, its revenue growth should remain strong for several years, says MKM's Rob Sanderson, reiterating a Buy and $86 target.</li>\n<li>\n<a href=\"http://www.streetinsider.com/Analyst+Comments/Yelp+%28YELP%29+is+a+Misunderstood%2C+High+Growth+Stock+-+MKM+Partners/10126245.html\" target=\"_blank\">Sanderson observes</a> less than 20% of Yelp's geographic footprint is currently responsible for 70% of its revenue. The monetization of newer markets - a majority of markets are currently pre-revenue - is seen boosting revenue growth and driving margin expansion. \"While YELP has higher sales expense than large scale digital ad platforms, it has no content costs, no traffic acquisition costs and lower infrastructure costs.\"</li>\n<li>Yelp is down 21% YTD, and 47% from a March high of $101.75. Shares still go for 7.3x 2015E sales. They sold off in October due to the Q4 guidance and <a href=\"https://seekingalpha.com/news/2051085-yelp-minus-13_5-percent-ah-on-light-guidance-slowing-visitor-growth\" target=\"_blank\">user growth figures</a> provided with a Q3 beat.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200145\" data-linked=\"Yelp gains following bullish MKM note\" data-tweet=\"$YELP - Yelp gains following bullish MKM note https://seekingalpha.com/news/2200145-yelp-gains-following-bullish-mkm-note?source=tweet\" data-url=\"https://seekingalpha.com/news/2200145-yelp-gains-following-bullish-mkm-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200115\" data-ts=\"1419955792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCLP\" target=\"_blank\">HCLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200115-fracking-sand-plays-sell-off-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fracking sand plays sell off again</a></h4><ul>\n<li>With WTI crude now trading near $54/barrel, fracking sand plays Hi-Crush Partners (<a href=\"https://seekingalpha.com/symbol/HCLP\" title=\"Hi-Crush Partners LP\">HCLP</a> <font color=\"red\">-4.3%</font>), U.S. Silica (<a href=\"https://seekingalpha.com/symbol/SLCA\" title=\"U.S. Silica\">SLCA</a> <font color=\"red\">-2.7%</font>), and Emerge Energy (<a href=\"https://seekingalpha.com/symbol/EMES\" title=\"Emerge Energy Services LP\">EMES</a> <font color=\"red\">-7.5%</font>) are posting fresh losses.</li>\n<li>Baker Hughes <a href=\"http://www.bloomberg.com/news/2014-12-29/oil-rigs-in-u-s-drop-by-37-to-lowest-level-since-april.html\" target=\"_blank\">has reported</a> U.S. rigs targeting oil fell by 37 in the week ending Dec. 26 to 1,499. Idle rigs were at their highest level since 2012. Nonetheless, Goldman thinks U.S. producers might further boost production (already at its highest levels in more than three decades) in an attempt to grab share from OPEC, albeit while moving rigs to lower-cost fields.</li>\n<li>Several SA authors have defended U.S. Silica (<a href=\"https://seekingalpha.com/article/2679435-silica-the-critical-ingredient-that-makes-shale-rock-bleed-oil\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/article/2768745-is-this-the-best-investment-in-shale-oil\" target=\"_blank\">II</a>, <a href=\"https://seekingalpha.com/article/2742595-im-not-calling-a-bottom-in-crude-oil-but-heres-why-i-bought-u-s-silica\" target=\"_blank\">III</a>, <a href=\"https://seekingalpha.com/article/2776615-why-im-all-in-on-u-s-silica\" target=\"_blank\">IV</a>) over the last month, citing its valuation and a belief frac sand demand should remain healthy even if oil prices stay under pressure. The company <a href=\"https://seekingalpha.com/news/2195645-u-s-silica-to-boost-buyback-program-from-25m-to-as-much-as-50m\" target=\"_blank\">added to its buyback</a> last week.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200115\" data-linked=\"Fracking sand plays sell off again\" data-tweet=\"$HCLP $HCR $SLCA - Fracking sand plays sell off again https://seekingalpha.com/news/2200115-fracking-sand-plays-sell-off-again?source=tweet\" data-url=\"https://seekingalpha.com/news/2200115-fracking-sand-plays-sell-off-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2200015\" data-ts=\"1419953235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2200015-solarcity-down-4-percent-after-ceo-discloses-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarCity down 4% after CEO discloses sales</a></h4><ul>\n<li>SolarCity (SCTY) CEO Lyndon Rive discloses he <a href=\"http://www.insidermonkey.com/insider-trading/filing/5174555\" target=\"_blank\">sold 100K shares</a> on Christmas Eve at $56.61. 30K of the shares were obtained through the exercising of stock options priced at $1.62.</li>\n<li>Two weeks ago, CTO Peter Rive (Lyndon's brother and a fellow co-founder) <a href=\"http://www.insidermonkey.com/insider-trading/filing/5169782\" target=\"_blank\">disclosed the sale</a> of 125K shares at $50.43, following the exercising of options to purchase 37.5K shares at $1.62.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2200015\" data-linked=\"SolarCity down 4% after CEO discloses sales\" data-tweet=\"$TSLA - SolarCity down 4% after CEO discloses sales https://seekingalpha.com/news/2200015-solarcity-down-4-percent-after-ceo-discloses-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/2200015-solarcity-down-4-percent-after-ceo-discloses-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199985\" data-ts=\"1419951699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XGTI\" target=\"_blank\">XGTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199985-xg-technology-down-11_7-percent-in-early-trading\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">xG Technology down 11.7% in early trading</a></h4><ul><li>xG Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a>) is now <font color='red'>down 40%</font> since Feltl's Jeffrey Schreiner <a href=\"https://seekingalpha.com/news/2198265-xg-technology-down-8_5-percent-after-feltl-downgrade\" target=\"_blank\">downgraded</a> shares to Sell yesterday morning, while <a href=\"https://seekingalpha.com/news/2198945-xg-technology-now-minus-35_1-percent-feltl-worried-about-backlog-dilution\" target=\"_blank\">citing</a> backlog growth and share dilution concerns.</li><li>Shares now <font color='red'>-65%</font> YTD. 176K shares (above a 134K-share 3-month daily average) have already changed hands.</li></ul><div class=\"tiny-share-widget\" data-id=\"2199985\" data-linked=\"xG Technology down 11.7% in early trading\" data-tweet=\"$XGTI $XGTI-OLD - xG Technology down 11.7% in early trading https://seekingalpha.com/news/2199985-xg-technology-down-11_7-percent-in-early-trading?source=tweet\" data-url=\"https://seekingalpha.com/news/2199985-xg-technology-down-11_7-percent-in-early-trading\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199865\" data-ts=\"1419948704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199865-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NDRM' title='NeuroDerm'>NDRM</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/XNPT' title='XenoPort, Inc.'>XNPT</a> <font color='green'>+9%</font>. ARCP <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/CJJD' title='China Jo - Jo Drugstores, Inc.'>CJJD</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/JOB' title='GEE Group, Inc.'>JOB</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"2199865\" data-linked=\"Premarket Gainers / Losers\" data-tweet=\"$NDRM $XNPT $VER - Premarket Gainers / Losers https://seekingalpha.com/news/2199865-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2199865-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199815\" data-ts=\"1419947892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199815-repros-set-for-gap-up-at-the-open\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros set for gap up at the open</a></h4><ul>\n<li>Repros Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a>) is up <font color=\"green\">6%</font> premarket on light volume. After yesterday's close, the company announced the initiation of two Proellex clinical trials and progress on its Androxal NDA.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2199275-repros-initiates-trials-assessing-proellex-in-uterine-fibroids\" target=\"_blank\">Repros initiates trials assessing Proellex in uterine fibroids</a> (Dec. 29)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2199065-repros-moving-forward-with-androxal-nda\" target=\"_blank\">Repros moving forward with Androxal NDA</a> (Dec. 29)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2199815\" data-linked=\"Repros set for gap up at the open\" data-tweet=\"$RPRX - Repros set for gap up at the open https://seekingalpha.com/news/2199815-repros-set-for-gap-up-at-the-open?source=tweet\" data-url=\"https://seekingalpha.com/news/2199815-repros-set-for-gap-up-at-the-open\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199805\" data-ts=\"1419947623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRL\" target=\"_blank\">DRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199805-puerto-rico-to-appeal-doral-tax-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puerto Rico to appeal Doral tax ruling</a></h4><ul>\n<li>Doral Financial (NYSE:<a href=\"https://seekingalpha.com/symbol/DRL\" title=\"Doral Financial Corporation\">DRL</a>) soared 27% yesterday on hope the Puerto Rican government would not appeal a $229M tax judgement in favor of the struggling bank.</li>\n<li>A spokesman for the Commonwealth's Government Development Bank, however, says an appeal<a href=\"http://www.reuters.com/article/2014/12/29/usa-puertorico-doral-idUSL1N0UD1KC20141229\" target=\"_blank\"> will be filed</a> this week.</li>\n<li>Shares are<font color=\"red\"> lower by 5.9%</font> in very light premarket trading.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2199805\" data-linked=\"Puerto Rico to appeal Doral tax ruling\" data-tweet=\"$DRL - Puerto Rico to appeal Doral tax ruling https://seekingalpha.com/news/2199805-puerto-rico-to-appeal-doral-tax-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/2199805-puerto-rico-to-appeal-doral-tax-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199785\" data-ts=\"1419947528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGBL\" target=\"_blank\">NGBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199785-medbox-to-restate-financial-statements\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medbox to restate financial statements</a></h4><ul>\n<li>Medication dispensing equipment maker Medbox (MDBX) plans to amend and restate its financial statements for the year 2013, Q3 and Q4 of 2013 and the first three quarters of 2014. The statements for the Q1 and Q2 2013 and full-year 2012 may also require revision.</li>\n<li>In October, the BOD appointed a special board committee to investigate a federal grand jury subpoena that was served upon the firm's accountants and alleged wrongdoing by a former employee. The company itself was subsequently served by subpoenas from the federal grand jury. The SEC became involved after <a href=\"http://www.thedeal.com/content/regulatory/feds-probe-pot-dispensary-outfit-medbox.php\" target=\"_blank\">receiving a letter</a> from a Medbox ex-employee.</li>\n<li>It appears that revenues were recognized too soon on certain customer contracts. Up-front payments will now be amortized over the longer of the contract period or the customer relationship and revenue will be deferred until key contingencies are removed and it is clear that the revenue is earned per GAAP and SEC regulations.</li>\n<li>The situation permits the Medbox's existing lenders to trigger default remedies but they have deferred taking action pending discussions on refinancing the company.</li>\n<li>MDBX is down <font color=\"red\">13%</font> premarket on turnover of 750 shares.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2199785\" data-linked=\"Medbox to restate financial statements\" data-tweet=\"$NGBL - Medbox to restate financial statements https://seekingalpha.com/news/2199785-medbox-to-restate-financial-statements?source=tweet\" data-url=\"https://seekingalpha.com/news/2199785-medbox-to-restate-financial-statements\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199735\" data-ts=\"1419945926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDRM\" target=\"_blank\">NDRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199735-neuroderm-ld-cd-candidates-deliver-high-levodopa-levels-in-pd-patients-in-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeuroDerm LD/CD candidates deliver high levodopa levels in PD patients in study</a></h4><ul>\n<li>Thinly-traded nano cap NeuroDerm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NDRM\" title=\"NeuroDerm\">NDRM</a>) is up <font color=\"green\">16%</font> premarket on light volume in response to its announcement of clinical trial results for its levodopa/carbidopa (LD/CD) product candidates in Parkinson's disease (PD).</li>\n<li>In a 16-subject Phase 2a study, patients with advanced PD, with motor fluctuations and chronically treated with oral LD/CD, were administered <a href=\"http://neuroderm.com/nd0612-for-moderate-pd/\" target=\"_blank\">NDO612L </a>(n=9) and <a href=\"http://neuroderm.com/nd0650-for-severe-pd/\" target=\"_blank\">ND0612H </a>(n=7) for eight hours per day for three consecutive days, with high and low doses of CD and with adjunct oral <a href=\"http://en.wikipedia.org/wiki/Entacapone\" target=\"_blank\">entacapone</a>.</li>\n<li>Patients receiving NDO612H achieved maximum daytime levodopa plasma concentrations of up to 1,436 ng/mL and 1,807 ng/mL with the inclusion of entacapone. Patients receiving NDO612L achieved levodopa plasma levels of up to 528 ng/mL and 596 ng/mL with entacapone.</li>\n<li>Oral LD/CD is the standard of care for the treatment of PD. Maintaining consistent levodopa concentrations is problematic due to the short half-life (3 - 4 hours) of the drug and its low absorption rate via the oral route. This makes the management of OFF episodes more challenging. The other alternative is the surgical placement of a tube containing LD in the patient's duodenum.</li>\n<li>The company's LD/CD product candidates are continuously administered subcutaneously through a belt-worn pump.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2199735\" data-linked=\"NeuroDerm LD/CD candidates deliver high levodopa levels in PD patients in study\" data-tweet=\"$NDRM - NeuroDerm LD/CD candidates deliver high levodopa levels in PD patients in study https://seekingalpha.com/news/2199735-neuroderm-ld-cd-candidates-deliver-high-levodopa-levels-in-pd-patients-in-study?source=tweet\" data-url=\"https://seekingalpha.com/news/2199735-neuroderm-ld-cd-candidates-deliver-high-levodopa-levels-in-pd-patients-in-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199635\" data-ts=\"1419943312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XNPT\" target=\"_blank\">XNPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199635-xenoport-up-on-bullish-call-from-rbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenoport up on bullish call from RBC</a></h4><ul>\n<li>Xenoport (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XNPT\" title=\"XenoPort, Inc.\">XNPT</a>) is up <font color=\"green\">13%</font> premarket albeit on turnover of only 3,000 shares. After yesterday's close, RBC's Michael Yee said the company is his <a href=\"http://www.benzinga.com/media/cnbc/14/12/5109674/cnbcs-fast-money-cnbcfastmoney-tweet-rbcs-michael-yee-says-xenoport-is-his-\" target=\"_blank\">\"under the radar\"</a> play for 2015.</li>\n<li>The company develops products for the treatment of neurological disorders. It is currently commercializing <a href=\"http://www.horizant.com/\" target=\"_blank\">Horizant </a>(gabapentin enacarbil) for the treatment of restless legs syndrome and for the management of pain from damaged nerves following the healing of shingles (postherpetic neuralgia). It is developing products for the treatment of psoriasis, multiple sclerosis and Parkinson's disease.</li>\n<li>Consensus views for 2014 and 2015 are losses of ($0.87) and ($1.18) on revenues of $46.9M and $38.9M, respectively.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2199635\" data-linked=\"Xenoport up on bullish call from RBC\" data-tweet=\"$XNPT - Xenoport up on bullish call from RBC https://seekingalpha.com/news/2199635-xenoport-up-on-bullish-call-from-rbc?source=tweet\" data-url=\"https://seekingalpha.com/news/2199635-xenoport-up-on-bullish-call-from-rbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2199465\" data-ts=\"1419933780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2199465-european-equities-sink-on-oil-greek-worries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European equities sink on oil, Greek worries</a></h4><ul>\n<li>European shares are in the red, tracking a weaker showing in Asia, with sentiment staying cautious as Greek politics remain at the forefront of concern and oil continues its collapse to fresh 5-1/2-year lows.</li>\n<li>The Athens General index <font color=\"red\">fell a further 0.6%</font>, after plunging 12% yesterday following a failed presidential vote.</li>\n<li>FTSE 100 <font color=\"red\">-0.7</font>; DAX <font color=\"red\">-0.7</font>; CAC 40 <font color=\"red\">-0.6</font>; Euro Stoxx 50 <font color=\"red\">-0.6</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2199465\" data-linked=\"European equities sink on oil, Greek worries\" data-tweet=\"European equities sink on oil, Greek worries https://seekingalpha.com/news/2199465-european-equities-sink-on-oil-greek-worries?source=tweet\" data-url=\"https://seekingalpha.com/news/2199465-european-equities-sink-on-oil-greek-worries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":25,"message":null,"success":true,"today":{"start":1576904400,"end":1576990799,"str":"Saturday, December 21, 2019"},"yesterday":{"start":1576818000,"end":1576904399}}